Hepatic failure and hepatorenal syndrome secondary to erlotinib. Safety reminder.
Year: 2008
Type: other
Source: PubMed
Author: Muhammad Wasif Saif
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2116416993
